SYSTEM PROBLEMS:
We are currently experiencing technical problems with content and functionality requiring a login.
We apologize for the inconvience.
Showing session: reset
COVID-19 EPIDEMIOLOGY
- Sort by:
|
<< first | < prev
page:
of 1
|
records per page:
next > | last >>
|
| pages: 1
|
presentations:
1 to
17 of
17
|
SARS-COV-2 TESTING & POSITIVITY AMONG PERSONS WITH & WITHOUT HIV IN 6 US COHORTS (ABSTRACT
626)
Lesley S Park
Stanford University School of Medicine, Palo Alto, CA, USA
SARS-COV-2 SEROPREVALENCE AND IGG LEVELS ARE LOWER AMONG PEOPLE LIVING WITH HIV (ABSTRACT
627)
Matthew Spinelli
University of California San Francisco, San Francisco, CA, USA
A POPULATION-BASED ANALYSIS OF SARS-COV-2 AMONG PATIENTS ON ART OR PREP (ABSTRACT
628)
Kate Salters
British Columbia Centre for Excellence in HIV/AIDS, Vancouver, Canada
SEROPREVALENCE OF ANTIBODIES AGAINST SARS-COV-2 AMONG PEOPLE LIVING WITH HIV (PLWH) (ABSTRACT
629)
Smitha Gudipati
Henry Ford Hospital, Berkeley, MI, USA
SUSTAINED SEROPREVALENCE IN HEALTH CARE WORKERS AT A QUATERNARY CENTER, NEW YORK CITY (ABSTRACT
630)
Delivette Castor
Columbia University, New York, NY, USA
OVERCROWDED HOUSING INCREASES RISK FOR COVID-19 MORTALITY: AN ECOLOGICAL STUDY (ABSTRACT
631)
Karan Varshney
Vancouver Coastal Health, Vancouver, British Columbia, Canada
DYNAMICS OF THE COVID-19 EPIDEMIC AT THE CALIFORNIA-MEXICO BORDER (ABSTRACT
632)
Davey M Smith
University of California San Diego, San Diego, CA, USA
A DESCRIPTION AND ANALYSIS OF COVID-19 IN A POPULATION-REPRESENTATIVE COHORT (ABSTRACT
633)
Yannis Herrmann
Heidelberg University Hospital, Heidelberg, Germany
SARS-COV-2 SURVEILLANCE IN 14 HEALTH FACILITIES IN MALAWI (ABSTRACT
634)
Karam Sachathep
Columbia University, New York, NY, USA
SARS-COV-2 TRANSMISSION AMONG FIRST CASES AND THEIR CONTACTS IN KISUMU COUNTY, KENYA (ABSTRACT
635)
Margaret Mburu
Kenya Medical Research Institute, Kisumu, Kenya
CUMULATIVE INCIDENCE OF SARS-COV-2 INFECTION AND EPIDEMIC METRICS, UNITED STATES (ABSTRACT
636)
Patrick S Sullivan
Emory University, Atlanta, GA, USA
RECENT SARS-COV-2 SEROCONVERSION IN A NATIONAL PROSPECTIVE COHORT OF US ADULTS (ABSTRACT
637)
Denis Nash
CUNY Graduate School of Public Health and Health Policy, New York, NY, USA
US POPULATION-BASED SURVEY OF VACCINE WILLINGNESS AND SARS-COV-2 ANTIBODY PREVALENCE (ABSTRACT
638)
Aaron J Siegler
Emory University, Atlanta, GA, USA
SARS-COV-2 GENETIC DIVERSITY INCREASED AT LEAST 3-FOLD IN THE US IN 2020 (ABSTRACT
639)
Adam A Capoferri
National Cancer Institute-Frederick, Frederick, MD, USA
PREVALENCE OF ANTI–SARS-COV-2 ANTIBODIES IN SOUTH AFRICAN BLOOD DONORS (ABSTRACT
640)
Laurette Mhlanga
Stellenbosch University, Stellenbosch, western Cape, South Africa
A PROSPECTIVE CASE-COHORT STUDY OF COVID-19 IN PERSONS WITH HIV: COVIH-19 STUDY (ABSTRACT
641)
Jose L Blanco
Hospital Clinic, Barcelona, Outside USA or Canada, Spain
DETERMINANTS OF COVID-19 HOSPITAL OUTCOMES IN A LARGE PENNSYLVANIA HEALTH SYSTEM (ABSTRACT
642)
Pamela A Shaw
University of Pennsylvania, Philadelphia, PA, USA
|
<< first | < prev
page:
of 1
|
records per page:
next > | last >>
|
| pages: 1
|
presentations:
1 to
17 of
17
|
